Author Guidelines
Type of Manuscripts
The Nigerian Journal of Pharmaceutical and Applied Science Research is an international Open Access journal devoted to the promotion of pharmaceutical sciences and related disciplines (including biotechnology, cell and molecular biology, drug utilization including adverse drug events, medical and other life sciences, and related engineering fields). It seeks particularly (but not exclusively) to encourage pharmaceutical and allied research of tropical relevance and to foster multidisciplinary research and collaboration among scientists, the pharmaceutical industry and healthcare professionals. It also provides an international forum for the communication and evaluation of data, methods and findings in pharmaceutical sciences and related disciplines. Although primarily devoted to original research papers, the journal welcomes reviews on current topics of special interest and relevance.
All manuscripts are subject to rapid peer review. Those of high quality (not previously published and not under consideration for publication in another journal) are published without delay.
The maximum length of manuscripts should be 6000 words (24 double-spaced typewritten pages) for review, 4000 words (18 pages) for research articles, and 1,500 (6 pages) for technical notes, commentaries and short communications.
Submission of Manuscript
All manuscripts (must be in English and MS Word format) and should be submitted via our online system. The e-mail addresses (or telephone numbers) of all authors must be provided. Illustrations (figures) should be in computer format. Images for any manuscript should not exceed 200 kilobytes unless prior authorization is received from the editor-in-chief. Authors may submit the names, affiliations and addresses (including e-mail) of expert reviewers or those they do not want to review their papers.
This journal does not accept manuscripts that are simultaneously being considered by another or other journals or have already been published elsewhere. Thus, authors are required to include the following statement in the Comments to the Editor:
"This manuscript submitted has not been previously published, nor is it before another journal for consideration"
NIJOPHASR subscribes to 'Standards for Authors available at http://publicationethics.org/international-standards-editors-and-authors or http://www.ncbi.nlm.nih.gov/)
Ethical Matters
Authors using experimental animals and human subjects in their investigation must seek approval from the appropriate Ethical Committee under "Principles of Laboratory Animal Care" (NIH publication no. 85-23, revised 1985) and/or the declaration of Helsinki promulgated in 1964 as amended in 1996. The method section must include a statement to prove that the investigation was approved and that informed consent was obtained.
Manuscript Format
The preferred format of all manuscripts is MS Word or RTF. Illustrations (figures) and images must be inserted in the manuscript at the position they should appear when published.
